LifeStance Health Group Inc

LifeStance Health Group Inc(LFST)の株式分析

$11.740

-0.598 (-5.09%)終値時点

Loading chart…
高値
12.490
始値
12.450
出来高加重平均価格
11.97
出来高
2.82M
時価総額
1.87B
安値
11.680
売買代金
33.81M
EV/EBITDA(TTM)
23.82

LifeStance Health Group, Inc. is a reimagining mental health company. The Company is focused on providing virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Its patient-focused platform combines differentiated clinical capabilities with a personalized, digitally powered patient experience designed to transform patient access and treatment. Its clinicians offer patients a comprehensive, multidisciplinary suite of mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders and post-traumatic stress disorder. It employs approximately 8,300 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers.

AI分析 of LifeStance Health Group Inc (LFST)

買い

LifeStance Health Group Inc is a good buy right now due to its current price of $11.74 being significantly below analyst price targets, which range up to $19. Additionally, the company's strong revenue growth is evident with a year-to-date change of +68.68% and a one-year change of +127.52%. The main risk is the recent insider selling, with the CTO selling 42,067 shares, representing 17% of his holdings, which may raise concerns about insider confidence.

バリュエーション指標

LifeStance Health Group Inc(LFST)の現在の予想PERは52.63で、5年平均は8.52です。

予想PER

適正
5年平均 P/E
8.52
現在のP/E
52.63
割高
104.33
割安
-87.28

予想EV/EBITDA

適正
5年平均 EV/EBITDA
35.21
現在のEV/EBITDA
23.82
割高
50.72
割安
19.70

予想PSR

適正
5年平均 P/S
2.29
現在のP/S
2.40
割高
3.15
割安
1.44

Alphio AI による LFST の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%LFST

$8.88

シナリオ価格

基

基本

基本 · 50%LFST

$8.02

シナリオ価格

弱

弱気

弱気 · 25%LFST

$6.83

シナリオ価格

LFST を保有するクジラ

I

Integral Health Asset Management, LLC

+ を保有LFST

-8.91%

3か月リターン

T

TPG Capital, L.P.

+ を保有LFST

-9.38%

3か月リターン

イベントタイムライン

2026-09-09 (ET)

09:00:00

Barclays Acts as Sole Book Running Manager for Offering

07:30:00

LifeStance Health Group to Offer 22.25M Shares of Common Stock

2026-08-10 (ET)

12:30:00

LifeStance Stock Rises 13.2% to $12.27

2026-08-06 (ET)

07:01:00

2026 Consensus Adjusted EBITDA Forecast $215M-$235M

07:01:00

Sees Q3 Adjusted EBITDA of $49M-$59M

ニュース

LFST のよくある質問 — Alphio AI が回答

LifeStance Health Group, Inc. is a reimagining mental health company. The Company is focused on providing virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Its patient-focused platform combines differentiated clinical capabilities with a personalized, digitally powered patient experience designed to transform patient access and treatment. Its clinicians offer patients a comprehensive, multidisciplinary suite of mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders and post-traumatic stress disorder. It employs approximately 8,300 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers. It operates in the Healthcare sector (SERVICES-HEALTH SERVICES industry).

LifeStance Health Group Inc is a good buy right now due to its current price of $11.74 being significantly below analyst price targets, which range up to $19. Additionally, the company's strong revenue growth is evident with a year-to-date change of +68.68% and a one-year change of +127.52%. The main risk is the recent insider selling, with the CTO selling 42,067 shares, representing 17% of his holdings, which may raise concerns about insider confidence.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める